Pneumococcal 15-Valent Conjugate Vaccine Approved for Pediatric Use
For children, Vaxneuvance is administered as a 4-dose series at 2, 4, 6 and 12 through 15 months of age (and at least 2 months after the 3rd dose).
Pediatrics
Disparities in Obesity Rates Seen Among US Adolescents
The researchers found that the trend in adjusted obesity prevalence increased over 20 years, particularly among adolescents from low-SES households.
Pediatric Emergency Encounters for Physical Abuse Down During Pandemic
Pediatric emergency medical encounters related to physical abuse were reduced during the COVID-19 pandemic.
With CDC Approval, COVID-19 Shots for Children Yonger than 5 Ready for Delivery
After a final sign-off on Saturday from the head of the U.S. CDC, COVID-19 vaccines for children younger than 5 years have finally become a reality.
No Increase Seen in Pediatric Hepatitis in the United States
No increase in pediatric hepatitis or adenovirus types 40/41 has been seen recently in the United States.
FDA Panel to Weigh Moderna Vaccine for Those Aged 6 to 17
The U.S. FDA’s vaccine advisory panel will decide whether to give EUA of Moderna’s COVID-19 vaccine in children aged 6 to 17.
Intrapartum Antibiotics Led to Increase in Resistant, Late-Onset Group B Streptococcal Disease
Researchers assessed the influence of intrapartum antibiotic prophylaxis on the emergence of antimicrobial resistant Group B streptococcal isolates.
Menthol Increases Smoking Frequency in Youth
The addition of menthol to cigarettes may increase smoking frequency and nicotine dependence among youth.
Clinical Practice Guidelines for COVID-19 Management in Children Are Inconsistent
Researchers assessed variations among clinical practice guidelines on the management of COVID-19 in children.
Immunity to Omicron Low for Children With Prior COVID-19 Infection
For pediatric patients with prior COVID-19 or MIS-C, cross-reactive immunity against the SARS-CoV-2 omicron variant is low.
- Loading...
Loading...
Next post in COVID19
Loading... 
Loading...